Temsirolimus
NDC 65219-200, Temsirolimus, kit, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-200
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- KIT
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207383
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-200-05 | 65219020005 | 1 KIT in 1 KIT (65219-200-05) * 1 mL in 1 VIAL, SINGLE-DOSE (65219-205-05) * 1.8 mL in 1 VIAL, SINGLE-DOSE (65219-202-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1c207bed-10e3-46f0-ad2c-69d5e5c97736Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-200
Use it
Look up 65219-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.